GnRH for Luteal Support in IVF/ICSI/FET Cycles
This study is looking at whether a single shot of GnRH (gonadotropin-releasing hormone) can improve the chances of a live birth for women undergoing IVF/ICSI (in vitro fertilization/intracytoplasmic sperm injection) or frozen embryo transfers (FET). You might be able to join if you are a woman between 18 and 40 years old who is having one of these fertility treatments. The study will compare GnRH to a placebo (an inactive substance) to see if GnRH helps more women have a live birth. The main goal is to see how many live births occur per embryo transfer, measured at 9 months after the transfer. The current recruitment status is unclear.
- Study design
- This interventional study plans to enroll 350 women. Participants will receive either a single shot of GnRH or a placebo.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for live birth per transfer, measured at 9 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
GnRH for Luteal Support in IVF/ICSI/FET Cycles
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Peter G McGovern, MD · PRINCIPAL_INVESTIGATOR · Rutgers University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Live birth per transfer9 months